ClearPoint Neuro

CLPT

----

Current ValuationThe current P/E ratio is -8.61, within the reasonable range, cheaper than 21.26% of the time in the past 5 years, and the industry ranks 127/173, the industry Median -0.78.

-8.61xP/E

Stock price$9.71Earnings per share$-1.13

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

013263952

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
GKOSUSGlaukos	-80.95x	90.98%	$13.75B
BAXUSBaxter	-18.24x	166.27%	$13.19B
TFXUSTeleflex	-5.75x	118.39%	$5.93B
IRTCUSIRhythm	-298.67x	53.96%	$4.17B
PLSEUSPulse Biosciences	-46.51x	26.85%	$3.72B
AXGNUSAxogen	-90.98x	12.42%	$2.90B
ASSTUSStrive	-2.63x	57.99%	$2.56B
BFLYUSButterfly Network	-31.88x	36.13%	$1.71B
KMTSUSKestra Medical Tech	-11.34x	0.79%	$1.70B
NVCRUSNovocure	-12.90x	13.66%	$1.57B
DRTSUSAlpha Tau Medical	-13.50x	--	$1.25B
TNDMUSTandem Diabetes	-19.40x	77.60%	$1.23B
ENOVUSEnovis	-1.09x	100.97%	$1.20B
AORTUSArtivion	-362.27x	266.67%	$1.16B
PRCTUSPROCEPT BioRobotics	-10.53x	3.47%	$1.16B
ATECUSAlphatec	-13.34x	51.67%	$1.16B
CBLLUSCeribell	-16.44x	36.22%	$1.08B
SIBNUSSI-BONE	-77.84x	23.19%	$1.07B
QDELUSQuidelOrtho	-0.92x	75.33%	$966.23M
BBNXUSBeta Bionics	-9.88x	13.23%	$820.94M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.